For educational purposes only — not tax, legal, or financial advice. Tax laws change frequently. Consult a qualified CPA, Enrolled Agent, or tax attorney for your specific situation.

    Skip to main content
    TaxKilnUS tax guidance
    All Tools
    Sponsorship slot availableSponsor this tool →

    US R&D Tax Credit (§41) + §174 Expensing (2026)

    Compare the §41 Regular Credit against the Alternative Simplified Credit (ASC), elect the QSB payroll-tax offset, and model the OBBBA-restored §174 immediate expensing regime — including the 2022–2024 retroactive catch-up that undoes the five-year amortization software businesses suffered through.

    Guidance, not advice. This calculator runs the rules as published, it doesn't assess your circumstances. Your actual tax may be affected by factors it doesn't cover (deductions, credits, filing status nuances, state-specific adjustments). Always seek financial or tax advice from a qualified CPA, Enrolled Agent, or tax attorney, or contact the IRS. Read our editorial scope →

    OBBBA restored §174 immediate domestic expensing
    The One Big Beautiful Bill Act (July 2025) permanently restored full first-year expensing for domestic research and experimental (R&E) expenditures, ending the 5-year amortization regime that the TCJA imposed from 2022. If you capitalized domestic R&E costs for 2022–2024, the residual balance can be deducted on your 2025 return via the prescribed accounting-method change. Foreign R&E remains on a 15-year straight-line amortization.

    Qualified research expenditures

    Wages for qualified services, supplies consumed in research, 65% of US contract research, and 100% of cloud-computing expenses for QRE projects.

    Default 3% for start-ups (no QRE before 1984 or first 5 years).

    §41 credit — recommended: Regular Credit

    Pick whichever method produces the larger credit; the election is annual and revocable until the return is filed.

    Regular Credit (20%)

    $120,000

    Base amount: $600,000 — credit on QRE above base.

    ASC (14%)

    $119,000

    Base = 50% × average QRE of prior 3 years.

    §174 R&E expensing (2026 OBBBA regime)

    Unamortized residual of domestic R&E you capitalized for tax years 2022–2024. Deductible on the 2025 return via the prescribed §446 accounting-method change.

    Domestic — expensed in full$1,000,000
    Foreign — 15-yr amortization, this year$0
    Current-year §174 deduction$1,000,000

    State R&D credit — California
    15.0%

    15% on QRE above base + 24% basic-research credit. Carryforward indefinite, no refund.

    State R&D credit$90,000
    Combined federal + state credit value$210,000